Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 5
1966 2
1967 2
1968 6
1969 3
1970 2
1971 2
1972 2
1973 1
1974 10
1975 1
1976 4
1977 6
1978 7
1979 13
1980 13
1981 5
1982 10
1983 8
1984 19
1985 15
1986 9
1987 1
1988 6
1989 4
1990 15
1991 5
1992 12
1993 5
1994 12
1995 17
1996 7
1997 21
1998 23
1999 30
2000 47
2001 42
2002 13
2003 12
2004 4
2005 10
2006 12
2007 12
2008 21
2009 20
2010 13
2011 11
2012 15
2013 9
2014 11
2015 11
2016 14
2017 9
2018 10
2019 13
2020 12
2021 31
2022 20
2023 23
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Results by year

Filters applied: . Clear all
Page 1
Response to commentary.
Hirasawa Y, Nakada TA, Terada J. Hirasawa Y, et al. J Intensive Care. 2021 Sep 15;9(1):56. doi: 10.1186/s40560-021-00572-6. J Intensive Care. 2021. PMID: 34526154 Free PMC article.
Walsogynes H-O from Walsura chrysogyne.
Nugroho AE, Nakajima S, Wong CP, Hirasawa Y, Kaneda T, Shirota O, Tougan T, Horii T, Hadi AHA, Morita H. Nugroho AE, et al. Among authors: hirasawa y. J Nat Med. 2022 Jan;76(1):94-101. doi: 10.1007/s11418-021-01556-4. Epub 2021 Aug 5. J Nat Med. 2022. PMID: 34351584 Free PMC article.
COVID-19 mRNA Vaccine-induced Pneumonitis.
Matsuzaki S, Kamiya H, Inoshima I, Hirasawa Y, Tago O, Arai M. Matsuzaki S, et al. Among authors: hirasawa y. Intern Med. 2022 Jan 1;61(1):81-86. doi: 10.2169/internalmedicine.8310-21. Epub 2021 Oct 26. Intern Med. 2022. PMID: 34707048 Free PMC article.
[Teleradiology].
Hirasawa Y. Hirasawa Y. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009 Nov 20;65(11):1572-81. doi: 10.6009/jjrt.65.1572. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009. PMID: 20019439 Free article. Japanese. No abstract available.
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H. Tsujino T, et al. Among authors: hirasawa y. Cancer Med. 2023 Oct;12(19):19414-19422. doi: 10.1002/cam4.6536. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706578 Free PMC article.
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor.
Hamada K, Isobe J, Hattori K, Hosonuma M, Baba Y, Murayama M, Narikawa Y, Toyoda H, Funayama E, Tajima K, Shida M, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Sambe T, Tsuji M, Wada S, Kiuchi Y, Kobayashi S, Kuramasu A, Horiike A, Kim YG, Tsunoda T, Yoshimura K. Hamada K, et al. Among authors: hirasawa y. Front Immunol. 2023 May 3;14:1164724. doi: 10.3389/fimmu.2023.1164724. eCollection 2023. Front Immunol. 2023. PMID: 37207204 Free PMC article.
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
Tsujino T, Komura K, Inamoto T, Maenosono R, Hashimoto T, Adachi T, Hirasawa Y, Tokushige S, Ohno T, Yamazaki S, Fukushima T, Nakamura K, Yano Y, Nishimura K, Kinoshita S, Nakamori K, Tsutsumi T, Matsunaga T, Yoshikawa Y, Uchimoto T, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Takahara K, Ohno Y, Azuma H. Tsujino T, et al. Among authors: hirasawa y. World J Urol. 2023 Dec;41(12):3585-3591. doi: 10.1007/s00345-023-04687-3. Epub 2023 Nov 4. World J Urol. 2023. PMID: 37924336
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Murayama M, Hosonuma M, Kuramasu A, Kobayashi S, Sasaki A, Baba Y, Narikawa Y, Toyoda H, Isobe J, Funayama E, Tajima K, Sasaki A, Maruyama Y, Yamazaki Y, Shida M, Hamada K, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Horiike A, Sambe T, Tsuji M, Wada S, Kobayashi S, Shimane T, Tsunoda T, Kobayashi H, Kiuchi Y, Yoshimura K. Murayama M, et al. Among authors: hirasawa y. Sci Rep. 2024 May 17;14(1):11325. doi: 10.1038/s41598-024-59677-1. Sci Rep. 2024. PMID: 38760458 Free PMC article.
Antimalarial ceramicines Q-T from Chisocheton ceramicus.
Nugroho AE, Wong CP, Hirasawa Y, Kaneda T, Tougan T, Horii T, Hadi AHA, Morita H. Nugroho AE, et al. Among authors: hirasawa y. J Nat Med. 2023 Jun;77(3):596-603. doi: 10.1007/s11418-023-01706-w. Epub 2023 May 10. J Nat Med. 2023. PMID: 37162697 Free PMC article.
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.
Ohkuma R, Miura S, Muto S, Toyomasu Y, Fujimoto Y, Ieguchi K, Onishi N, Shimizu T, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Shimokawa M, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Mura E, Takenoshita S, Numajiri K, Okabe N, Yoshimura K, Tsuji M, Kiuchi Y, Yajima T, Ishida H, Suzuki H, Yamochi T, Kobayashi S, Tsunoda T, Wada S. Ohkuma R, et al. Among authors: hirasawa y. Front Immunol. 2023 Sep 18;14:1260492. doi: 10.3389/fimmu.2023.1260492. eCollection 2023. Front Immunol. 2023. PMID: 37790929 Free PMC article.
683 results